NASDAQ:EYEN Investor Notice: Investigation over Potential Wrongdoing at Eyenovia, Inc.

San Diego, CA -- (SBWire) -- 10/11/2023 --Certain directors of Eyenovia, Inc. are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of Eyenovia, Inc. (NASDAQ: EYEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Eyenovia, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

New York based Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. Eyenovia, Inc. went public in January 2018.

Since then, shares of Eyenovia, Inc. (NASDAQ: EYEN) declined from $10.74 per share on January 25, 2018 to as low as $1.48 per share on October 10, 2023.

Those who purchased shares of Eyenovia, Inc. (NASDAQ: EYEN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.